These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 18636350)

  • 21. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.
    Vasen HF; Watson P; Mecklin JP; Lynch HT
    Gastroenterology; 1999 Jun; 116(6):1453-6. PubMed ID: 10348829
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence of pedigrees suggestive of hereditary nonpolyposis colorectal cancer among a community sample of women eligible for screening mammography.
    Ramsey SD; Freedman AN; Berry K; Andersen MR; Urban N
    Community Genet; 1999; 2(4):173-8. PubMed ID: 14960838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New diagnostic criteria for HNPCC are on the way.
    Kuska B
    J Natl Cancer Inst; 1997 Jan; 89(1):11-2. PubMed ID: 8978400
    [No Abstract]   [Full Text] [Related]  

  • 24. NCCN increases the emphasis on genetic/familial high-risk assessment in colorectal cancer.
    Hampel H
    J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):829-31. PubMed ID: 24853227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the impact of genetic counseling and testing with signal detection methods.
    Palmer CG; Hadley DW
    J Genet Couns; 2005 Feb; 14(1):17-27. PubMed ID: 15789153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. When should we suspect hereditary colorectal cancer syndrome?
    Llor X
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):363-7; quiz e39; e41. PubMed ID: 22178459
    [No Abstract]   [Full Text] [Related]  

  • 27. The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics program.
    Mukherjee A; McGarrity TJ; Ruggiero F; Koltun W; McKenna K; Poritz L; Baker MJ
    Hered Cancer Clin Pract; 2010 Nov; 8(1):9. PubMed ID: 21092199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic counselling protocols for hereditary non-polyposis colorectal cancer: a survey of UK regional genetics centres.
    Brain K; Soldan J; Sampson J; Gray J
    Clin Genet; 2003 Mar; 63(3):198-204. PubMed ID: 12694229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel allele of the hMLH1 gene bearing a TTC deletion in the 3' untranslated region.
    Palmirotta R; Veri M; Curia MC; Casale V; Fracasso P; Stigliano V; Guadagni F; Marianicostantini R; Battista P; Cama A
    Int J Oncol; 1996 Oct; 9(4):701-3. PubMed ID: 21541571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version).
    National Health Commission Of The People's Republic Of China
    Chin J Cancer Res; 2020 Aug; 32(4):415-445. PubMed ID: 32965276
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiplex SNaPshot genotyping for detecting loss of heterozygosity in the mismatch-repair genes MLH1 and MSH2 in microsatellite-unstable tumors.
    Bujalkova M; Zavodna K; Krivulcik T; Ilencikova D; Wolf B; Kovac M; Karner-Hanusch J; Heinimann K; Marra G; Jiricny J; Bartosova Z
    Clin Chem; 2008 Nov; 54(11):1844-54. PubMed ID: 18772310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Causes and consequences of microsatellite instability in endometrial carcinoma.
    Gurin CC; Federici MG; Kang L; Boyd J
    Cancer Res; 1999 Jan; 59(2):462-6. PubMed ID: 9927063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled.
    Beck NE; Tomlinson IP; Homfray T; Hodgson SV; Harocopos CJ; Bodmer WF
    Br J Surg; 1997 Feb; 84(2):233-7. PubMed ID: 9052445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer.
    Mauillon JL; Michel P; Limacher JM; Latouche JB; Dechelotte P; Charbonnier F; Martin C; Moreau V; Metayer J; Paillot B; Frebourg T
    Cancer Res; 1996 Dec; 56(24):5728-33. PubMed ID: 8971183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic mutations of a human mismatch repair gene, hMLH1, in tumors from patients with multiple primary cancers.
    Sasaki S; Horii A; Shimada M; Han HJ; Yanagisawa A; Muto T; Nakamura Y
    Hum Mutat; 1996; 7(3):275-8. PubMed ID: 8829664
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer.
    Konishi M; Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Onda A; Okumura Y; Kishi N; Iwama T; Mori T; Koike M; Ushio K; Chiba M; Nomizu S; Konishi F; Utsunomiya J; Miyaki M
    Gastroenterology; 1996 Aug; 111(2):307-17. PubMed ID: 8690195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of mismatch repair genes, hMLH1 and hMSH2, in sporadic endometrial carcinomas with microsatellite instability.
    Kobayashi K; Matsushima M; Koi S; Saito H; Sagae S; Kudo R; Nakamura Y
    Jpn J Cancer Res; 1996 Feb; 87(2):141-5. PubMed ID: 8609062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations of GTBP in genetically unstable cells.
    Papadopoulos N; Nicolaides NC; Liu B; Parsons R; Lengauer C; Palombo F; D'Arrigo A; Markowitz S; Willson JK; Kinzler KW
    Science; 1995 Jun; 268(5219):1915-7. PubMed ID: 7604266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical value of screening hereditary nonpolyposis colorectal cancer in China with protocol recommended by NCCN guidelines].
    Shen K; Wang S; Ye YJ; Yin MJ; Yang XD; Xu F; Liang B; Jiang KW; Cui ZR
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):317-21. PubMed ID: 18636350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
    Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H
    Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.